Acer Therapeutics logo
Acer Therapeutics ACER

Quartalsbericht 2023-Q3
hinzugefügt 20.11.2023

report update icon

Acer Therapeutics Langfristiger Schuldenstrom 2011-2026 | ACER

Langfristiger Schuldenstrom Jährlich Acer Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
104 K 184 K 274 K 263 K - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
274 K 104 K 206 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
7.09 M $ 20.29 -1.98 % $ 2.56 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.8 -5.3 % $ 4.36 M chinaChina
Axsome Therapeutics Axsome Therapeutics
AXSM
434 K $ 166.0 -0.23 % $ 8.26 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 3.74 -2.23 % $ 1.12 B canadaCanada
Certara Certara
CERT
3.92 M $ 7.22 2.34 % $ 1.16 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
437 K $ 23.78 -0.42 % $ 2.91 B usaUSA
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
1.37 M $ 18.17 1.57 % $ 873 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
5.38 M $ 17.9 -1.38 % $ 459 M usaUSA
Exelixis Exelixis
EXEL
27.9 M $ 40.5 -1.29 % $ 11 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
19 K $ 2.89 -5.56 % $ 180 M usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
749 K $ 26.3 -2.08 % $ 704 M usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Codexis Codexis
CDXS
2.83 M $ 1.02 -0.33 % $ 74.9 M usaUSA
Galapagos NV Galapagos NV
GLPG
3.48 M $ 33.13 -2.82 % $ 2.69 B belgiumBelgium
Galecto Galecto
GLTO
183 K $ 29.63 -1.41 % $ 787 M danmarkDanmark
Genmab A/S Genmab A/S
GMAB
26 M $ 27.66 -6.71 % $ 17.7 B danmarkDanmark
Halozyme Therapeutics Halozyme Therapeutics
HALO
13.3 M $ 68.58 -1.82 % $ 8.22 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Hoth Therapeutics Hoth Therapeutics
HOTH
28.4 K $ 1.0 -1.47 % $ 6.38 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
1.07 M $ 28.32 -2.01 % $ 1.63 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
432 K $ 6.3 -3.67 % $ 51.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
Agenus Agenus
AGEN
2.59 M $ 3.27 -2.1 % $ 1.17 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
18.4 M $ 28.57 -2.16 % $ 1.66 B usaUSA
Immuron Limited Immuron Limited
IMRN
34.4 K $ 0.75 -0.69 % $ 6.46 M australiaAustralia
Immatics N.V. Immatics N.V.
IMTX
1.88 M $ 10.09 1.0 % $ 635 M germanyGermany
Immunic Immunic
IMUX
470 K $ 1.13 6.61 % $ 176 M usaUSA
Immunovant Immunovant
IMVT
98 K $ 27.09 -2.38 % $ 4.11 B usaUSA
Inhibrx Inhibrx
INBX
2.06 M $ 76.39 -1.42 % $ 3.6 B usaUSA
InMed Pharmaceuticals InMed Pharmaceuticals
INM
376 K $ 0.8 -2.44 % $ 1.96 M canadaCanada